Natalia Callaway

Natalia Callaway, MD, MS, is a Senior Medical Director at Genentech, specializing in early research and development in ophthalmology since September 2019. With extensive experience in clinical development, Callaway has led multiple Phase 1-3 clinical trials and served as a medical director on significant studies, including the Phase 3 ARCHWAY trial for the FDA-approved product SUSVIMO. In addition to the role at Genentech, Callaway holds the position of Clinical Assistant Professor of Ophthalmology at Byers Eye Institute at Stanford, focusing on vitreoretinal surgery and resident education. Prior experience includes a residency at the Bascom Palmer Eye Institute and a research role at Johns Hopkins School of Medicine, leading to multiple peer-reviewed publications. Educational background includes an MD from Stanford University and an MS in Health Research Services from the same institution, alongside a BA in Biology and Neuroscience from The Johns Hopkins University.